Affiliation:
1. Mothers and Babies Research Centre, Hunter Medical Research Institute, Newcastle 2305, Australia
2. School of Medicine and Public Health, University of Newcastle, Newcastle 2308, Australia
3. Wisdom Lake Academy of Pharmacy, Xi’an Jiao Tong Liverpool University, Suzhou 215123, China
4. Australian Synchrotron, Australian Nuclear Science and Technology Organisation, Clayton 3168, Australia
5. School of Chemistry and Physics, Queensland University of Technology, Brisbane 4000, Australia
6. Central Analytical Research Facility, Queensland University of Technology, Brisbane 4000, Australia
Abstract
Placental health and foetal development are dependent upon element homeostasis. Analytical techniques such as mass spectroscopy can provide quantitative data on element concentrations in placental tissue but do not show spatial distribution or co-localisation of elements that may affect placental function. The present study used synchrotron-based X-ray fluorescence microscopy to elucidate element content and distribution in healthy and pathological placental tissue. The X-ray fluorescence microscopy (XFM) beamline at the Australian Synchrotron was used to image trace metal content of 19 placental sections from healthy term (n = 5, 37–39 weeks), foetal growth-restricted (n = 3, <32 weeks, birth weight <3rd centile), postdate (n = 7, >41 completed weeks), and stillbirth-complicated pregnancies (n = 4, 37–40 weeks). Samples were cryo-sectioned and freeze-dried. The concentration and distribution of fourteen elements were detected in all samples: arsenic, bromine, calcium, chlorine, copper, iron, molybdenum, phosphorous, potassium, rubidium, selenium, strontium, sulphur, and zinc. The elements zinc, calcium, phosphorous, and strontium were significantly increased in stillbirth placental tissue in comparison to healthy-term controls. Strontium, zinc, and calcium were found to co-localise in stillbirth tissue samples, and calcium and strontium concentrations were correlated in all placental groups. Molybdenum was significantly decreased in stillbirth, foetal growth-restricted, and postdate placental tissue in comparison to healthy-term samples (p < 0.0001). Synchrotron-based XFM reveals elemental distribution within biological samples such as the placenta, allowing for the co-localisation of metal deposits that may have a pathological role. Our pilot study further indicates low concentrations of placental molybdenum in pregnancies complicated by foetal growth restriction, postdate delivery, and stillbirth.
Funder
Australian Nuclear Science and Technology Organisation
National Health and Medical Research Council
Reference54 articles.
1. Placental Origins of Chronic Disease;Burton;Physiol. Rev.,2016
2. Lean, S.C., Heazell, A.E.P., Dilworth, M.R., Mills, T.A., and Jones, R.L. (2017). Placental Dysfunction Underlies Increased Risk of Fetal Growth Restriction and Stillbirth in Advanced Maternal Age Women. Sci. Rep., 7.
3. Placental insufficiency and its consequences;Gagnon;Eur. J. Obstet. Gynecol. Reprod. Biol.,2003
4. Biomarkers of inflammation and placental dysfunction are associated with subsequent preterm birth;Bastek;J. Matern.-Fetal Neonatal Med.,2011
5. Intrauterine programming of adult disease;Barker;Mol. Med. Today,1995